Literature DB >> 32483355

The genomic landscape of recurrent pancreatic cancer is modified by treatment.

Irene Y Xie1, Steven Gallinger2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32483355     DOI： 10.1038/s41575-020-0321-9

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  2 in total

1.  Serum osteocalcin concentration in patients with prostatic cancer.

Authors:  G Francini; S Bigazzi; V Leone; C Gennari
Journal:  Am J Clin Oncol       Date:  1988       Impact factor: 2.339

2.  The Evolutionary Origins of Recurrent Pancreatic Cancer.

Authors:  Hitomi Sakamoto; Marc A Attiyeh; Jeffrey M Gerold; Alvin P Makohon-Moore; Akimasa Hayashi; Jungeui Hong; Rajya Kappagantula; Lance Zhang; Jerry P Melchor; Johannes G Reiter; Alexander Heyde; Craig M Bielski; Alexander V Penson; Mithat Gönen; Debyani Chakravarty; Eileen M O'Reilly; Laura D Wood; Ralph H Hruban; Martin A Nowak; Nicholas D Socci; Barry S Taylor; Christine A Iacobuzio-Donahue
Journal:  Cancer Discov       Date:  2020-03-19       Impact factor: 38.272
  2 in total
  3 in total

1.  Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer.

Authors:  Xuan Han; Wu-Hu Zhang; He-Li Gao; Tian-Jiao Li; Hua-Xiang Xu; Hao Li; Peng-Cheng Li; Xu Wang; Xian-Jun Yu; Wen-Quan Wang; Liang Liu
Journal:  J Clin Lab Anal       Date:  2022-05-27       Impact factor: 3.124

2.  Prognosis and survival analysis of patients with pancreatic cancer: retrospective experience of a single institution.

Authors:  Qi Li; Zijian Feng; Ruyi Miao; Xun Liu; Chenxi Liu; Zhen Liu
Journal:  World J Surg Oncol       Date:  2022-01-07       Impact factor: 2.754

3.  Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival.

Authors:  Julie Earl; Emma Barreto; María E Castillo; Raquel Fuentes; Mercedes Rodríguez-Garrote; Reyes Ferreiro; Pablo Reguera; Gloria Muñoz; David Garcia-Seisdedos; Jorge Villalón López; Bruno Sainz; Nuria Malats; Alfredo Carrato
Journal:  Cancers (Basel)       Date:  2021-03-31       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.